Skip to main content
Fig. 2 | Cell & Bioscience

Fig. 2

From: A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma

Fig. 2

Pathway enrichment analysis and drug sensitivity assessment of copper-induced cell death genes. A Heatmap of multiple cancer-related pathways for copper-induced cell death. B The activation of the inhibition pathway in multiple cancers. C The copper-induced death potential index (CPI) in cancer and normal tissues. D The association between the expression levels of copper-induced cell death-related genes and patient outcomes. E The drug sensitivity assessment of several copper-induced cell death-related genes to molecular inhibitors

Back to article page

Cell & Bioscience

ISSN: 2045-3701

Contact us